Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Albuferon albumin-interferon alpha: Final Phase II data

Human Genome Sciences Inc. (HGSI), Rockville, Md.
Novartis AG (NVS; SWX:NOVN), Basel, Switzerland
Product: Albuferon albumin-interferon alpha
Business: Infectious

Read the full 203 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE